Literature DB >> 27030493

Diagnostic Accuracy of the Small Membrane Filtration Method for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Prevalence Setting.

Yap Boum1,2, Soyeon Kim3, Patrick Orikiriza1,2, Carlos Acuña-Villaorduña4, Solange Vinhas5, Maryline Bonnet1,6, Dan Nyehangane1, Juliet Mwanga-Amumpaire1,2, Kevin P Fennelly7, Edward C Jones-López8.   

Abstract

Sputum acid-fast bacilli (AFB) smear microscopy has suboptimal sensitivity but remains the most commonly used laboratory test to diagnose pulmonary tuberculosis (TB). We prospectively evaluated the small membrane filtration (SMF) method that concentrates AFB in a smaller area to facilitate detection to improve the diagnostic performance of microscopy. We enrolled adults with suspicion of pulmonary TB from health facilities in southwestern Uganda. Clinical history, physical examination, and 3 sputum samples were obtained for direct fluorescent AFB smear, SMF, Xpert MTB/RIF, and MGIT culture media. Sensitivity and specificity were estimated for SMF, AFB smear, and Xpert MTB/RIF, using MGIT as the reference standard. The analysis was stratified according to HIV status. From September 2012 to April 2014, 737 participants were included in the HIV-infected stratum (146 [20.5%] were culture positive) and 313 were in the HIV-uninfected stratum (85 [28%] were culture positive). In HIV-infected patients, the sensitivity of a single SMF was 67.4% (95% confidence interval [CI], 59.9% to 74.1%); for AFB, 68.0% (95% CI, 60.6% to 74.6%); and for Xpert MTB/RIF, 91.0% (95% CI, 85.0% to 94.8%). In HIV-uninfected patients, the corresponding sensitivities were 72.5% (95% CI, 62.1% to 80.9%), 80.3% (95% CI, 70.8% to 87.2%), and 93.5% (95% CI, 85.7% to 97.2%). The specificity for all 3 tests in both HIV groups was ≥96%. In this setting, the SMF method did not improve the diagnostic accuracy of sputum AFB. The Xpert MTB/RIF assay performed well in both HIV-infected and -uninfected groups.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27030493      PMCID: PMC4879284          DOI: 10.1128/JCM.00017-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

Review 1.  Light-emitting diode technologies for TB diagnosis: what is on the market?

Authors:  Jessica Minion; Hojoon Sohn; Madhukar Pai
Journal:  Expert Rev Med Devices       Date:  2009-07       Impact factor: 3.166

2.  Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV.

Authors:  Maryline Bonnet; Andrew Ramsay; Willie Githui; Laramie Gagnidze; Francis Varaine; Philippe J Guerin
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

3.  Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy.

Authors:  Patrícia Quincó; Samira Bührer-Sékula; Walber Brandão; Rossiclea Monte; Silvia Leopoldina Souza; Valeria Saraceni; Moises Palaci; Reynaldo Dietze; Marcelo Cordeiro-Santos
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

4.  False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results.

Authors:  T H Boyles; J Hughes; V Cox; R Burton; G Meintjes; M Mendelson
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

5.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

Review 6.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

7.  Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.

Authors:  Andrea Pantoja; Christopher Fitzpatrick; Anna Vassall; Karin Weyer; Katherine Floyd
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

8.  Evaluation of combined LED-fluorescence microscopy and bleach sedimentation for diagnosis of tuberculosis at peripheral health service level.

Authors:  Maryline Bonnet; Laramie Gagnidze; Philippe J Guerin; Laurence Bonte; Andrew Ramsay; Willie Githui; Francis Varaine
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  Evaluation of bleach-sedimentation for sterilising and concentrating Mycobacterium tuberculosis in sputum specimens.

Authors:  Rusheng Chew; Carmen Calderón; Samuel G Schumacher; Jonathan M Sherman; Luz Caviedes; Patricia Fuentes; Jorge Coronel; Teresa Valencia; Beatriz Hererra; Mirko Zimic; Lucy Huaroto; Ivan Sabogal; A Rod Escombe; Robert H Gilman; Carlton A Evans
Journal:  BMC Infect Dis       Date:  2011-10-11       Impact factor: 3.090

10.  Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards.

Authors:  Patricia Scolari Fontela; Nitika Pant Pai; Ian Schiller; Nandini Dendukuri; Andrew Ramsay; Madhukar Pai
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  4 in total

1.  Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2019-06-07

2.  Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

Authors:  Adrienne E Shapiro; Jennifer M Ross; Mandy Yao; Ian Schiller; Mikashmi Kohli; Nandini Dendukuri; Karen R Steingart; David J Horne
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

3.  Detection and Quantification of Mycobacterium tuberculosis in the Sputum of Culture-Negative HIV-infected Pulmonary Tuberculosis Suspects: A Proof-of-Concept Study.

Authors:  Guillermo Madico; Moses Mpeirwe; Laura White; Solange Vinhas; Beverley Orr; Patrick Orikiriza; Nancy S Miller; Mary Gaeddert; Juliet Mwanga-Amumpaire; Moises Palaci; Barry Kreiswirth; Joe Straight; Reynaldo Dietze; Yap Boum; Edward C Jones-López
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

4.  Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance.

Authors:  Divya Anthwal; Surabhi Lavania; Rakesh Kumar Gupta; Ajoy Verma; Vithal Prasad Myneedu; Prem Prakash Sharma; Hitesh Verma; Viveksheel Malhotra; Ashawant Gupta; Nalini Kant Gupta; Rohit Sarin; Sagarika Haldar; Jaya Sivaswami Tyagi
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.